Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions

Healthy Adults

Interventions

DRUG

CORT113176

CORT113176 lipid capsule formulation for oral administration

DRUG

Placebo matching CORT113176

Placebo matching CORT113176 lipid capsule formulation for oral administration

Trial Locations (1)

Site 01, Groningen